Zydus Lifesciences is developing a combination vaccine targeting shigellosis and typhoid, with support from the Gates ...

India's Zydus Lifesciences declared it would purchase an 85.6 per cent ownership in France's Amplitude Surgical for 256.8 ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus Lifesciences, said, “Preventives are the key to public health in both the developing and the developed world and vaccines have the potential to improve the quality of life. In India ...

"Preventives are the key to public health in both the developing and the developed world and vaccines have the potential to improve the quality of life," Zydus Lifesciences Managing Director ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

The 25th anniversary also celebrates the dedicated team at Vashi. Their expertise and adaptability have driven the site's success, exemplifying the shared values of Zydus and Takeda which are ...

Our mission is to ensure that transplant patients get access to affordable, life-saving treatment." With ANVIMO, Zydus Lifesciences is transforming CMV prophylaxis in India, ensuring that more ...

Zydus Lifesciences share price will remain in focus on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.